哈兽研品牌怎么样 申请店铺

我要投票 哈兽研在兽药行业中的票数:15 更新时间:2024-11-22
哈兽研是哪个国家的品牌?「哈兽研」是 哈尔滨维科生物技术有限公司 旗下著名品牌。该品牌发源于黑龙江哈尔滨市,由创始人付董在1992年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
哈兽研怎么样

成立于1992年,国内知名的全系列禽流感疫苗制造品牌,专业从事动物疫病防治用生物制品的研发、生产、销售、技术咨询与服务的兽用生物制品企业


哈尔滨维科生物技术有限公司(简称维科生物)是中国农业科学院哈尔滨兽医研究所(简称哈兽研)独资的一人有限责任公司,是农业部禽流感疫苗生产企业和技术依托单位。

维科生物成立于1992年,专门从事动物疫病防治用生物制品的研发、生产、销售、技术咨询与服务,是具有独立法人资格的企业,主要是对哈兽研科技成果进行孵化、转化及孵化后的推广。

维科生物现有员工中具有大专以上学历人员超过70%,其中高级职称人员4人,副高级职称人员21人,具有博士、硕士以上学位人员62人。中高级职称人员中,绝大多数是哈兽研所获科技成果的完成人。

公司新址落成于2008年,并于2009年7月整体通过农业部兽用生物制品GMP验收。新址园区面积约11.4万平方米,建筑面积6.2万平方米,共有17条生产线,主要设备为进口,自动化程度高,工艺优良。另有国家禽流感疫苗抗原储备库、质量检验、研发、动物实验、立体仓储等配套设施。

依托维科生物的黑龙江兽用生物制品工程技术研究中心与哈尔滨市兽用生物制品工程研究中心运行良好。经国家发改委立项与批准,维科生物参股组建的动物用生物制品国家工程研究中心也已正式运行。

维科生物生产的历代禽流感疫苗均在禽流感疫情防控中得到了广泛应用,解决了不同禽种的有效免疫问题,为我国禽流感疫情的防控做出重要贡献。目前维科生物的禽流感疫苗已在越南、埃及、印尼广泛应用。

我公司秉承“团结、奉献、求实、创新”的哈兽研精神,本着“责任重于泰山,细节决定成败”的企业文化理念,以维护动物健康和保障动物性食品安全为宗旨,以追踪兽用生物制品技术前沿为目标,高起点地为畜牧业发展服务,并努力将企业发展成为出色的兽用生物制品企业。


Founded in 1992, Harbin Weike Biotechnology Co., Ltd. (hereinafter referred to as "Weike biotechnology") is a famous brand of avian influenza vaccine manufacturing in China, specializing in the R & D, production, sales, technical consultation and service of biological products for animal disease prevention and control. It is a wholly-owned one person limited liability company of Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences (hereinafter referred to as "Harbin Veterinary Research") The company is an avian influenza vaccine manufacturer and technical support unit of the Ministry of agriculture. Founded in 1992, Vico biology specializes in the R & D, production, sales, technical consultation and service of biological products for animal disease prevention and control. It is an enterprise with independent legal personality, which mainly incubates, transforms and promotes the scientific and technological achievements of Harbin animal research. At present, more than 70% of the employees have college degree or above, including 4 with senior professional title, 21 with deputy senior professional title, 62 with doctor's degree or above. Most of the middle and senior professional titles are the Achievers of scientific and technological achievements of Harbin animal research institute. The company's new site was completed in 2008 and passed the GMP acceptance of animal biological products by the Ministry of agriculture in July 2009. The new site covers an area of about 114000 square meters, with a building area of 62000 square meters. There are 17 production lines. The main equipment is imported, with high degree of automation and excellent technology. There are also national avian influenza vaccine antigen storage, quality inspection, research and development, animal experiments, three-dimensional storage and other supporting facilities. Heilongjiang animal biological products engineering technology research center and Harbin animal biological products Engineering Research Center Based on Vico biology are in good operation. With the approval of the national development and Reform Commission, the National Engineering Research Center for animal biological products, which was established with the participation of Vico biology, has also been officially put into operation. All the avian influenza vaccines produced by Vico biology have been widely used in the prevention and control of avian influenza epidemic, which solved the effective immune problems of different avian species and made important contributions to the prevention and control of avian influenza epidemic in China. At present, the avian influenza vaccine of vyco has been widely used in Vietnam, Egypt and Indonesia. Our company adheres to the spirit of "unity, dedication, truth-seeking and innovation", the corporate culture concept of "responsibility is more important than Mount Tai, details determine success or failure", the purpose of maintaining animal health and ensuring animal food safety, the goal of tracking the forefront of animal biological products technology, the high starting point for animal husbandry development services, and strive to develop the enterprise into an excellent animal use Biological products enterprises.

本文链接: https://brand.waitui.com/19aeb19ab.html 联系电话:400-999-1948,0451-51661114

千城特选小程序码

7×24h 快讯

李彦宏:百度文库AI功能月活用户超5000万,同比增长超300%

36氪获悉,百度2024年第三季度财报电话会上,百度创始人、董事长兼首席执行官李彦宏披露,今年9月,百度文库AI功能月活用户突破5000万,同比增长超300%。此外,用户的付费意愿不断增强,第三季度文库的订阅收入同比增长23%。在近期举办的百度世界2024上,百度文库与百度网盘联合推出了工具类智能体“自由画布”,亮相首日即吸引超20万人排队预约。

2小时前

李彦宏:Q3智能云营收快速增长,AI收入占比提升至超11%

36氪获悉,在百度2024年第三季度财报电话会上,百度创始人、董事长兼首席执行官李彦宏公布,三季度,百度智能云营收达49亿元,同比增长11 %,Non-GAAP 经营利润率同比提升。其中,AI相关收入占比持续提升至超11%。据IDC报告,在中国AI公有云市场,百度智能云已连续五年位居第一。

2小时前

热门中概股美股盘前普跌,拼多多跌超10%

36氪获悉,热门中概股美股盘前普跌,截至发稿,拼多多跌超10%,小鹏汽车、爱奇艺跌超4%,百度、B站跌超2%,蔚来跌超1%。

2小时前

我国载人登月任务已全面进入初样研制阶段

中国载人航天工程总设计师周建平21日在深圳召开的第六届载人航天学术大会上表示,我国载人月球探测工程载人登月任务已经完成了前期的关键技术攻关和深化论证,目前全面进入了初样研制阶段。“目前,长征十号运载火箭、梦舟载人飞船、揽月月面着陆器、载人月球车等初样产品正在紧张研制过程中。不少初样产品已经研制出来,正在进行相关测试。”周建平说。(新华社)

2小时前

李彦宏:百度将于2025年初发布新版大模型

36氪获悉,在百度2024年第三季度财报电话会上,百度创始人、董事长兼首席执行官李彦宏透露,百度将于2025年初发布文心大模型的新版本,以巩固在基础模型上的领先优势。李彦宏表示,11月,文心大模型日均调用量达15亿,日均处理Tokens文本超1.7万亿。相较一年前首次披露的5000万次日均调用量,增长30倍。

2小时前

本页详细列出关于哈兽研的品牌信息,含品牌所属公司介绍,哈兽研所处行业的品牌地位及优势。
咨询